Am J Transplant, Volume 5, Suppl 3 Archives - Page 11 of 170 - ATC Abstracts

2015 American Transplant Congress
Risk Factors for Acute Cellular Rejection for Pediatric Kidney Transplant Recipients
D. Cote,¹ I. Bobanga,¹ B. Vogt,² K. Dell,² R. Cunningham III,² K. Noon,¹ V. Humphreville,¹ E. Sanchez,¹ J. Schulak,¹ K. Woodside.¹
¹Department of Surgery, Case Western Reserve University & University Hospitals, Cleveland, OH; ²Department of Pediatrics, Case Western Reserve University & University Hospitals, Cleveland, OH.
Background: Acute cellular rejection (ACR) potentially shortens the life of a kidney allograft. We sought to determine risk factors associated with the development of ACR…
2015 American Transplant Congress
Pregnancy Outcomes in Female Kidney Recipients Who Conceived Before Age 20
L. Coscia,¹ D. Armenti,¹ S. Constantinescu,² M. Moritz.¹
¹National Transplantation Pregnancy Registry, Gift of Life Institute, Philadelphia; ²Medicine, Temple University School of Medicine, Philadelphia; ³Lehigh Valley Health Network, Allentown.
The purpose of this study was to examine the pregnancy outcomes among female kidney recipients who conceived before age 20. Data were collected by the…
2015 American Transplant Congress
The Impact of Critical Illness and Pre-Transplant Hospitalization on Cost of Liver Transplantation
S. Knechtle, L. Brummett, S. Perez.
Surgery, Emory University School of Medicine, Atlanta, GA.
In order to understand the cost impact of hospitalization and ICU admission immediately prior to liver transplantation (LT), we obtained all hospital costs associated with…
2015 American Transplant Congress
Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients
L. Donohue, W. Ally, S. Dunn, J. Kennedy, J. Bergin.
University of Virginia Health System, Charlottesville, VA.
Background: Calcineurin inhibitors (CNI) are essential agents in most orthotopic heart transplantation (OHT) anti-rejection regimens. However, nephrotoxicity limits their use in the immediate post-OHT period,…
2015 American Transplant Congress
Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates
J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
¹University of Alabama, Birmingham, Birmingham, AL; ²SRTR, MMRF, Minneapolis, MN; ³Johns Hopkins Univerity, Baltimore, MD.
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease patients. As OPTN does not collect HIV status at waitlisting, no…
2015 American Transplant Congress
Tolerant Kidney Transplant Patients Display B Cells With Regulatory Properties
S. Brouard,^1,2 M. Chesneau,^1,3 L. Michel,^1,2,3 E. Dugast,^1,3 A. Chenouard,^1,3 A. Pallier,¹ D. Baron,^1,3 J. Durand,^1,3 F. Braza,^1,3 P. Guerif,² D.-A. Laplaud,^1,2,3 J.-P. Soulillou,^1,2,3 M. Giral,^1,2,3 N. Degauque,^1,3 E. Chiffoleau,^1,3 S. Brouard.^1,2
¹INSERM UMR 1064, Nantes, France; ²CHU de Nantes, ITUN, Nantes, France; ³Université de Nantes, Faculté de Médecine, Nantes, France.
Whereas a B cell transcriptional profile has been recorded for operationally tolerant kidney graft patients, the role that B cells may play in this process…
2015 American Transplant Congress
Screening Recipients of Increased Risk Donor Organs: A Multicenter Study
N. Theodoropoulos,¹ K. Brizendine,² M. Ison.³
¹Infectious Diseases, The Ohio State University, Columbus, OH; ²Infectious Disease, Cleveland Clinic, Cleveland, OH; ³Infectious Diseases/Organ Transplantation, Northwestern University, Chicago, IL.
Purpose: Policy mandates post-transplant (tx) evaluation of recipients of increased risk donor organs (ROIRDO). PHS guidelines recommend that screening include HIV & hepatitis C virus…
2015 American Transplant Congress
Non-Invasive Panel of MicroRNAs Predict Long-Term Outcomes Post-Kidney Transplantation
J. Suh,¹ D. Maluf,¹ H. Cathro,² R. Gehrau,¹ I. McConnell,¹ K. Brayman,¹ C. Dumur,² V. Mas.¹
¹Surgery and Pathology, UVA, Charlottesville, VA; ²VCU, Richmond, VA.
Background. Currently available methods for evaluating kidney graft function post-transplantation (KT) are either ineffective or inaccurate (e.g., serum creatinine) or highly invasive (e.g., biopsies). We…
2015 American Transplant Congress
Changes in Health Related Quality of Life (HRQOL) in Pediatric Liver Transplant (LT) Recipients During Protocolized Immunosuppression Withdrawal (ISW): The iWITH Trial
S. Mohammad,¹ S. Sundaram,² V. Venkat,³ M. Martinez,⁴ J. Lopez,⁵ J. Magee,⁵ E. Alonso,¹ S. Feng.⁶
¹Northwestern U, Chicago; ²U of Colorado, Aurora; ³U of Pittsburgh, Pittsburgh; ⁴Columbia U., New York; ⁵U of Michigan, Ann Arbor; ⁶UCSF, San francisco.
ISW may limit medication-related comorbidities but intensive monitoring and unexpected rejection episodes may compromise HRQOL. We studied longitudinal HRQOL in pediatric LT recipients undergoing ISW…
2015 American Transplant Congress
The Selection Process for Total Artificial Heart
F. Arabia, L. Czer, M. Kittleson, E. Passano, F. Liou, J. Yabuno, H. Henry, D. Chang, F. Esmailian, J. Kobashigawa, J. Moriguchi.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: Heart failure patients with severe biventricular failure who are candidates for heart transplant are considered for Total Artificial Heart (TAH) support. These patients may…